A critical discovery in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This vital tumor inhibitor protein is frequently disabled in several types of malignancies, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research